Navigation Links
Personalized Medicine - The Genomic Revolution in Cardiac Care
Date:9/19/2007

WASHINGTON, Sept. 19 /PRNewswire-USNewswire/ --The Richard B. and Lynne V. Cheney Cardiovascular Institute and The Catherine Birch McCormick Genomics Center at The George Washington University host a cutting edge Symposium to examine the issues and implications around the growing forces of genomics and personalized medicine in cardiology. This symposium is intended to provide a valuable state-of-the-art update on the current status and future directions of the genomics of atherosclerotic cardiovascular disease, heart failure and cardiac arrhythmias, and the potential application to individualizing prevention, diagnosis and treatment for cardiac patients.

The practice of cardiovascular care has seen significant advances in the past 40 years with dramatic reduction of mortality from heart disease. Despite this major progress, cardiovascular disease remains the number one cause of death in the United States and is on the rise in developing countries. As we enter the 21st century there is much more we need to learn about the individualized patient disease susceptibility, progression, and treatment strategies. Medical molecular genetics is the next frontier with the potential to make dramatic breakthroughs in the prediction of disease and improvement of prevention, treatment, and quality of care.

The symposium agenda features luminaries in the field of genomics who will explore the state of cardiovascular genomics and how it relates to clinical practice. Keynote speakers include Elizabeth Nabel, MD, Director, National Heart, Lung, and Blood Institute to address: Genomics & Coronary Artery Disease, and Andrew Plump, MD, Ph.D., Director of Clinical Molecular Profiling, Merck & Co., to discuss: Genomics for Developing Biomarkers. The symposium provides a unique forum in its roster of prestigious speakers from academic, government and industry and in its ability to examine the issues and stimulate new ideas around personalized medicine as it relates to personalized cardiovascular care. Researchers, cardiologists, policy makers, medical industry and anyone with an interest in personalized medicine and genomics will want to attend.

"By identifying the genes that can cause and cure heart disease, researchers hold in their hands the potential for personalized medicine. Understanding research advances in the science of the human gene and its application to cardiovascular disease will make possible life saving changes in cardiac care," says Dr. Timothy McCaffrey, who is the program co-chair for the one-day symposium as well as director of the McCormick Genomics Center at The George Washington University. The McCormick Genomics Center is among the nation's innovative leaders in genomics research and application and is one of the few centers in the world to focus on cardiovascular genomic research. Dr. McCaffrey will lead a faculty of renowned experts, in the program.

"Leveraging the enormous resources of The George Washington University is a key part of how the Institute is approaching its mission to accelerate the pace of scientific discovery, reduce mortality and improve the quality of life of Americans with cardiovascular disease," said Dr. Richard J. Katz, who is the Director of the Cheney Cardiovascular Institute and Director of the Division of Cardiology. "An educational program like this one, on personalized medicine in cardiac care, holds the key to the next major advancements in cardiovascular care, which researchers, clinicians and policy makers must understand is one of the ways we're attacking cardiovascular disease and working to achieve our mission."

The symposium, titled "Personalized Medicine: The Genomic Revolution in Cardiac Care," is designated for 6 AMA PRA Category 1 Credits and will convene on October 25, 2007 at The George Washington University Hospital Auditorium, in Washington, DC. For more information about the symposium or to register, please visit http://www.cheneycardioinstitute.org.

ABOUT THE CHENEY CARDIOVASCULAR INSTITUTE

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006. The Institute's mission is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health-policy experts, and community leaders. For more information, please visit: http://www.cheneycardioinstitute.org.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
2. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
3. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
4. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
5. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
6. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
10. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
11. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):